09.12.2022 • Topics

PARTEC 2023: Call for Papers

The 2023 edition of PARTEC, the International Congress on Particle Technology, will take place on September 26−28, 2023 in Nuremberg, Germany. As one of the world's major scientific congresses for particle and bulk solids technology, it provides an international forum for R&D in new technologies.

The event brings together scientists and engineers from all over the world every three years and covers topics like particle formation, agglomeration and coating processes and diverse industrial applications for particles.

Experts on one of the main 2023 topics listed below are invited to submit an extended abstract and contribute a presentation to the congress.

PARTEC welcomes contributions from research universities, industrial companies and other research organizations. Industry specific and also joined research proposals between industry and research organizations are appreciated. Contributions covering all aspects of particle science and applications are welcome.

Submission deadline is January 15, 2023.

Main Topics of the 2023 event are:

  • Bulk powder technologies, gas-solid-multiphase flow
  • Comminution, breakage, agglomeration and granulation
  • Separation, fractionation and sorting
  • Mixing and dispersing, liquid-solid-multiphase flow
  • Wet synthesis and formation of particles
  • Product formulation, particle interactions, interfaces and stabilization
  • Innovative analytical methods for lab and production
  • Nano and aerosol particle technology
  • Particle technologies for sustainable products
  • Innovation in modelling and simulation

Click here to download the Call for Papers and to submit your abstract.

For more information, visit www.partec.info.

Photo

Company

Logo:

NürnbergMesse GmbH

Messezentrum
90471 Nürnberg
Germany

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read